The Business Research Company published its Artificial Intelligence (AI) In Drug Discovery Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Artificial Intelligence (AI) In Drug Discovery market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.
The report covers the AI In Drug Discovery market’s segments-
1) By Technology: Deep Learning, Machine Learning
2) By Drug Type: Small Molecule, Large Molecules
3) By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Others
4) By End-Users: Pharmaceutical Companies, Biopharmaceutical Companies, Academic and Research Institutes, Others.
View Complete Report:
Artificial Intelligence (AI) In Drug Discovery Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
The global AI in drug discovery market is expected to decline from $0.37 billion in 2019 to $0.36 million in 2020 at a compound annual growth rate (CAGR) of -1.33%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $1.1 billion in 2023 at a CAGR of 42.9%.
Major companies operating in the AI drug delivery market are adopting strategic collaborations to research and discover drugs using AI and are gaining significant popularity in the artificial intelligence in drug discovery market.
Few Points From Table Of Content
1. Executive Summary
2. Artificial Intelligence (AI) In Drug Discovery Market Characteristics
3. Artificial Intelligence (AI) In Drug Discovery Market Size And Growth
4. Artificial Intelligence (AI) In Drug Discovery Market Segmentation
5. Artificial Intelligence (AI) In Drug Discovery Market Regional And Country Analysis
25. Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Drug Discovery Market
27. Artificial Intelligence (AI) In Drug Discovery Market Trends And Strategies
28. Artificial Intelligence (AI) In Drug Discovery Market Future Outlook and Potential
Request A Sample Report At:
Few Points From List Of Table
Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 3: Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 47: IBM Corporation Financial Performance
Table 48: Microsoft Financial Performance
Table 49: Atomwise Inc. Financial Performance
Table 50: Deep Genomics Financial Performance
Table 51: Cloud Pharmaceuticals Financial Performance
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on Blog: http://blog.tbrc.info/
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company